The trajectory of Viagra, initially marketed by copyright, presents a intricate case study for backers considering the drug sector. While its groundbreaking success and generation of billions in revenue , the exclusivity lapse has opened the door for competing medications, greatly reducing income prospects . This transition raises doubts about the